Nearly 5,000 independent pharmacies have filed an antitrust and breach-of-contract lawsuit against Prime Therapeutics, LLC, ...
Pharmacy is a highly litigated corner of healthcare, with major fights running on four separate tracks: state laws banning PBMs from owning pharmacies, drugmakers challenging state 340B protections, ...
Many mail-order pharmacy customers feel trapped in a system that has left them with crushed pills, damaged vials and lifesaving drugs exposed to extreme weather. Bianca Bagnarelli / for NBC News ...
More mergers and acquisitions among pharmacy benefit management companies could follow the proposed combination of the PBMs Abarca Health and LucyRx.
Express Scripts (Cigna) offers three Medicare Part D prescription drug plans, among other services. Express Scripts Medicare Part D plans range in cost from low premiums and low copays to broad ...
As the Defense Department begins planning for the next-generation TRICARE pharmacy contract, which would succeed the current agreement currently administered by Express Scripts, lawmakers say the ...
Expenditures for specialty drugs account for more than 25 percent of total US drug spending and have been increasing at more than 13 percent annually. We examined insurers’ role in maintaining the ...
They have become the pariahs of the health care industry, blamed for exorbitant drug costs and ever-increasing medical bills by seemingly everyone on the political spectrum — from President Donald ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. For years, the drug-pricing debate in Washington has revolved around a ...
Years of debate and halting efforts to enact pharmacy benefit manager (PBM) reform came to a head in early 2026 with three independent but related federal actions, bringing with them substantial PBM ...
On February 4, 2026, the Federal Trade Commission (FTC) announced what it called a “landmark” settlement with Express Scripts, Inc. (ESI) in its enforcement action alleging anticompetitive practices ...